Losartan and Vitamin D Inhibit Colonic Tumor Development in a Conditional Apc-Deleted Mouse Model of Sporadic Colon Cancer
暂无分享,去创建一个
V. Konda | Wei Zhang | M. Bissonnette | J. Souris | Y. Li | J. Hart | J. Pekow | Jeffrey S Souris | R. Mustafi | U. Dougherty | L. Joseph | H. Haider | Abdurahman Khalil
[1] P. Crespo,et al. Mechanisms of action of vitamin D in colon cancer , 2019, The Journal of Steroid Biochemistry and Molecular Biology.
[2] A. Nishiyama,et al. (Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations , 2018, British Journal of Cancer.
[3] Andrew J. Gomes,et al. Early increase in blood supply (EIBS) is associated with tumor risk in the Azoxymethane model of colon cancer , 2018, BMC Cancer.
[4] Y. Kiniwa,et al. Involvement of local renin‐angiotensin system in immunosuppression of tumor microenvironment , 2017, Cancer science.
[5] R. Jain,et al. Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy , 2017, Science Translational Medicine.
[6] J. Qian,et al. E-cadherin Mediates the Preventive Effect of Vitamin D3 in Colitis-associated Carcinogenesis , 2017, Inflammatory bowel diseases.
[7] M. Tomita,et al. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC , 2017, Proceedings of the National Academy of Sciences.
[8] Elizabeth L. Barry,et al. Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial , 2017, JAMA oncology.
[9] M. Bissonnette,et al. Vitamin D and Calcium for Colorectal Adenoma Chemoprevention , 2017, Nutrition and cancer.
[10] V. Konda,et al. ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer , 2016, Clinical Cancer Research.
[11] M. Bissonnette,et al. Activation of the Renin-Angiotensin System Promotes Colitis Development , 2016, Scientific Reports.
[12] D. Pisano,et al. Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer , 2016, Gut.
[13] J. Manson,et al. Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence , 2016, British Journal of Nutrition.
[14] Yin Cao,et al. Aspirin and colorectal cancer: the promise of precision chemoprevention , 2016, Nature Reviews Cancer.
[15] Kathleen R. Cho,et al. Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium , 2015, PLoS genetics.
[16] G. Beck,et al. A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. , 2015, The New England journal of medicine.
[17] W. Goessling,et al. Accumulation of the Vitamin D Precursor Cholecalciferol Antagonizes Hedgehog Signaling to Impair Hemogenic Endothelium Formation , 2015, Stem cell reports.
[18] T. Hartman,et al. No Association Between Vitamin D Intake, VDR Polymorphisms, and Colorectal Cancer in a Population-Based Case–Control Study , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[19] C. Giardina,et al. Regulation of VDR Expression in Apc-Mutant Mice, Human Colon Cancers and Adenomas , 2015, Cancer Prevention Research.
[20] Camille Stephan-Otto Attolini,et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.
[21] V. Konda,et al. The Renin–Angiotensin System Mediates EGF Receptor–Vitamin D Receptor Cross-Talk in Colitis-Associated Colon Cancer , 2014, Clinical Cancer Research.
[22] X. Li,et al. Mechanisms of AT1a receptor-mediated uptake of angiotensin II by proximal tubule cells: a novel role of the multiligand endocytic receptor megalin. , 2014, American journal of physiology. Renal physiology.
[23] E. Giovannucci,et al. Vitamin D supplements and cancer incidence and mortality: a meta-analysis , 2014, British Journal of Cancer.
[24] Cynthia L Sears,et al. Microbes, microbiota, and colon cancer. , 2014, Cell host & microbe.
[25] E. Kallay,et al. Relative Expression of Vitamin D Hydroxylases, CYP27B1 and CYP24A1, and of Cyclooxygenase-2 and Heterogeneity of Human Colorectal Cancer in Relation to Age, Gender, Tumor Location, and Malignancy: Results from Factor and Cluster Analysis , 2012, Cancers.
[26] A. Ghasemi,et al. Normality Tests for Statistical Analysis: A Guide for Non-Statisticians , 2012, International journal of endocrinology and metabolism.
[27] H. DeLuca,et al. Supplementation by vitamin D compounds does not affect colonic tumor development in vitamin D sufficient murine models. , 2011, Archives of biochemistry and biophysics.
[28] F. Guerini,et al. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals , 2011, Brain, Behavior, and Immunity.
[29] Marc Bissonnette,et al. EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators , 2011, Molecular Cancer Research.
[30] Tasuku Honjo,et al. Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis , 2011, Gut.
[31] D. Rushton,et al. Ectodomain shedding of the Notch ligand Jagged1 is mediated by ADAM17, but is not a lipid-raft-associated event. , 2010, The Biochemical journal.
[32] R. Hannan,et al. The renin–angiotensin system and cancer: old dog, new tricks , 2010, Nature Reviews Cancer.
[33] R. Benya,et al. Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[34] D. Threadgill,et al. Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor- and PTGS2 , 2009, Clinical Cancer Research.
[35] A. Ruiz i Altaba,et al. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion , 2009, EMBO molecular medicine.
[36] J. Davis,et al. The Interaction of a High-Fat Diet and Regular Moderate Intensity Exercise on Intestinal Polyp Development in ApcMin/+ Mice , 2009, Cancer Prevention Research.
[37] S. Artavanis-Tsakonas,et al. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine , 2009, Proceedings of the National Academy of Sciences.
[38] L. Augenlicht,et al. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. , 2008, Carcinogenesis.
[39] G. Corner,et al. Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. , 2008, Cancer research.
[40] Qiang Yu,et al. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. , 2008, Cancer cell.
[41] T. Yao,et al. HDAC6 Is Required for Epidermal Growth Factor-induced β-Catenin Nuclear Localization* , 2008, Journal of Biological Chemistry.
[42] K. Hua,et al. Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. , 2007, Cell metabolism.
[43] Michal A. Kurowski,et al. Transcriptome Profile of Human Colorectal Adenomas , 2007, Molecular Cancer Research.
[44] Kathleen R. Cho,et al. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. , 2007, Cancer research.
[45] M. Bissonnette,et al. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model. , 2007, The Journal of surgical research.
[46] T. Yeatman,et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer , 2007, Genome Biology.
[47] J. Fleet,et al. High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice , 2007, The Journal of nutrition.
[48] M. Bissonnette,et al. Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis. , 2007, Cancer research.
[49] M. Neurath,et al. High resolution colonoscopy in live mice , 2006, Nature Protocols.
[50] P. Dempsey,et al. ADAM17 Mediates Epidermal Growth Factor Receptor Transactivation and Vascular Smooth Muscle Cell Hypertrophy Induced by Angiotensin II , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[51] S. Glenn,et al. Activation of the Rat Renin Promoter by HOXD10·PBX1b·PREP1, Ets-1, and the Intracellular Domain of Notch* , 2005, Journal of Biological Chemistry.
[52] M. Bertagnolli,et al. Apc Deficiency Is Associated with Increased Egfr Activity in the Intestinal Enterocytes and Adenomas of C57BL/6J-Min/+ Mice* , 2004, Journal of Biological Chemistry.
[53] F. Castellino,et al. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse. , 2003, Physiological genomics.
[54] J. Kong,et al. Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[55] D. Berrigan,et al. Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. , 2003, Cancer research.
[56] Shu Q. Liu,et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .
[57] T. Inagami,et al. Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis. , 2002, Carcinogenesis.
[58] D. Heber,et al. 1α, 25-(OH)2-D3 and its synthetic analogue decrease tumor load in the Apcmin mouse , 2002 .
[59] H. Hanai,et al. Immunohistochemical Localization of Angiotensin II Receptor and Local Renin-Angiotensin System in Human Colonic Mucosa , 2002 .
[60] H. Hanai,et al. Immunohistochemical Localization of Angiotensin II Receptor and Local Renin-Angiotensin System in Human Colonic Mucosa , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[61] Y. Hirose,et al. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. , 2001, Cancer research.
[62] A. Medline,et al. Possible mechanisms relating diet and risk of colon cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[63] R. DuBois,et al. Review article: cyclooxygenase – a target for colon cancer prevention , 2000, Alimentary pharmacology & therapeutics.
[64] Henrik Vorum,et al. An Endocytic Pathway Essential for Renal Uptake and Activation of the Steroid 25-(OH) Vitamin D3 , 1999, Cell.
[65] W F Bodmer,et al. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[66] M. Bissonnette,et al. 1α,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a Noncalcemic Analogue of 1α,25-Dihydroxyvitamin D3, Inhibits Azoxymethane-induced Colonic Tumorigenesis , 1995 .
[67] T. Bradstreet,et al. Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers. , 1993, Hypertension.
[68] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[69] M. Kahn,et al. Multiple genes of the renin-angiotensin system are novel targets of Wnt/β-catenin signaling. , 2015, Journal of the American Society of Nephrology : JASN.
[70] M. Bissonnette,et al. Inactivation of the vitamin D receptor in APCmin/+ mice reveals a critical role for the vitamin D receptor in intestinal tumor growth , 2012, International journal of cancer.
[71] D. Heber,et al. 1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse. , 2002, Cancer research.
[72] B. Pence,et al. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. , 1988, Carcinogenesis.